PHARMACEUTICAL COMPOSITIONS COMPRISING A QUINOLONE COMPOUND FOR IRRITABLE BOWEL SYNDROME

Title:

PHARMACEUTICAL COMPOSITIONS COMPRISING A QUINOLONE COMPOUND FOR IRRITABLE BOWEL SYNDROME

Document Type and Number:

WIPO Patent Application WO/2024/012421

Kind Code:

A1

Abstract:

Provided herein are pharmaceutical compositions comprising a quinolone compound for irritable bowel syndrome, especially provided is the use of the quinolone compound, in particular 1-cyclopropyl-6-fluoro-1, 4-dihydro-8-methyl-7- (2-amino-3-cyano-5-pyridyl) -4-oxo-3-quinoline-carboxylic acid or a pharmacologically acceptable salt, a hydrate, a solvate or a deuteride thereof for preventing or treating irritable bowel syndrome of a human or an animal.

Inventors:

CHEN SHIMEI (CN)
WEN JIE (CN)
CHENG JAY FEI (CN)
LIU FENGZHU (CN)
HU WEI (CN)

Application Number:

PCT/CN2023/106675

Publication Date:

January 18, 2024

Filing Date:

July 11, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

OTSUKA PHARMA CO LTD (JP)
CHEN SHIMEI (CN)

International Classes:

A61K31/4709; A61P1/00; A61P1/12

Domestic Patent References:

WO2020036154A1	2020-02-20
WO2021161983A1	2021-08-19
WO2021161982A1	2021-08-19
WO2021161981A1	2021-08-19
WO2013029548A1	2013-03-07

Attorney, Agent or Firm:

CHINA SINDA INTELLECTUAL PROPERTY LIMITED (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: UNIVERSAL CELL FOR EXPRESSING FASLG AND PREPARATION METHOD THEREFOR

Next Patent: HYDROGENATION CATALYST, PREPARATION METHOD THEREFOR, AND USE THEREOF